Toxicity management of chimeric antigen receptor T-cells

被引:0
|
作者
Le Bourgeois, Arnandine [1 ]
机构
[1] CHU Hotel Dieu, Serv Hematol Clin, F-44093 Nantes, France
关键词
CAR T-cells; Cytokine release syndrome; Tocilizumab; CAR-t-cell-related encephalopathy syndrome; CYTOKINE RELEASE SYNDROME; B-CELL; THERAPY; REMISSIONS; BIOMARKERS;
D O I
10.1016/S0007-4551(19)30049-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chimeric antigen receptor T-cells (CAR T-cells) represent a very promising treatment for both hematological malignancies and solid tumors. Many clinical trials are currently on-going to establish the role of this emerging therapy. The toxicities observed after CAR T-cells infusion are mostly represented by a cytokine release syndrome and neurological symptoms. Athough reversible, these adverse events remain associated with morbidity and mortality in patients. The objective of this review is to describe these adverse events, also discussing their physiopathology and management, based on the recent recommendations published by the CARTOX working group (CAR T-cell-therapy-associated TOXicity working group) in the US.
引用
收藏
页码:S188 / S197
页数:10
相关论文
共 50 条
  • [1] Chimeric Antigen Receptor T-Cells and Cardiovascular Toxicity Cause for Concern?
    Lancellotti, Patrizio
    Moonen, Marie
    Galderisi, Maurizio
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (25) : 3109 - 3111
  • [2] Chimeric Antigen Receptor T Cells: Toxicity and Management Considerations
    Owusu, Kent A.
    Schiffer, Molly
    Perreault, Sarah
    [J]. AACN ADVANCED CRITICAL CARE, 2022, 33 (04) : 301 - 307
  • [3] Chimeric Antigen Receptor T-Cells New Approaches to Improve Their Efficacy and Reduce Toxicity
    Maus, Marcela V.
    Powell, Daniel J., Jr.
    [J]. CANCER JOURNAL, 2015, 21 (06): : 475 - 479
  • [4] Gated chimeric antigen receptor T-cells: the next logical step in reducing toxicity?
    Davies, David Marc
    Maher, John
    [J]. TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S61 - S65
  • [5] A review of chimeric antigen receptor T-cells in lymphoma
    Anderson, Jennifer Kelly
    Mehta, Amitkumar
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2019, 12 (07) : 551 - 561
  • [6] THE CARDIOVASCULAR EFFECTS OF CHIMERIC ANTIGEN RECEPTOR T-CELLS
    Alvi, Raza M.
    Mahmood, Syed
    Hassan, Malek Z. O.
    Awadalla, Magid
    Zhang, Lili
    Mulligan, Connor P.
    Rokicki, Adam
    Raje, Noopur
    Abramson, Jeremy
    Frigault, Matthew J.
    Neilan, Tomas G.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 722 - 722
  • [7] Chimeric Antigen Receptor T-Cells: The Future Is Now
    Mchayleh, Wassim
    Bedi, Prabhjot
    Sehgal, Rajesh
    Solh, Melhem
    [J]. JOURNAL OF CLINICAL MEDICINE, 2019, 8 (02):
  • [8] Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
    Galli, Eugenio
    Bellesi, Silvia
    Viscovo, Marcello
    Sora, Federica
    Hohaus, Stefan
    Piccirillo, Nicola
    Laurenti, Luca
    Chiusolo, Patrizia
    De Stefano, Valerio
    Sica, Simona
    Zini, Gina
    [J]. MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2021, 13
  • [9] Allogeneic chimeric antigen receptor T-cells and multiple myeloma
    Malard, Florent
    [J]. HEMATOLOGIE, 2021, 27 : 13 - 18
  • [10] Chimeric antigen receptor modified T-cells for cancer treatment
    Xiao Han
    Yao Wang
    Wei-Dong Han
    [J]. 慢性疾病与转化医学(英文), 2018, 4 (04) : 225 - 243